Kewaunee Scientific Corp is engaged in the design, manufacture, and installation of laboratory, healthcare, and technical furniture and infrastructure products. Its products include steel and wood casework, fume hoods, adaptable modular systems, movable workstations, stand-alone benches, biological safety cabinets, epoxy resin work surfaces, and sinks. The company operates through two reportable segments: Lab Products Group (LPG), which designs, manufactures, and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, flexible systems, work surfaces, workstations, workbenches, and computer enclosures, and the International segment.
Last trade$0.00
Day change$0.00 (0.00%)
Day range$34.71 – $35.28
Volume60
Market cap$101M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$101.48M
Price / earnings
12.33×
Price / book
1.35×
Price / sales
0.37×
EV / sales
0.5×
EV / EBITDA
6.34×
Profitability
Earnings per share
$2.84
Return on assets
4.68%
Return on equity
10.97%
Dividend yield
0%
Liquidity and leverage
Debt / equity
0.61×
Current ratio
2.2×
Quick ratio
1.57×
Cash ratio
0.17×
Cash flow
Price / cash flow
6.85×
Price / free cash flow
9.33×
Free cash flow
$10.88M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for KEQU, quarterly periods
Line item
Q1 FY2027 Jul 31, 2026
Q4 FY2026 Apr 30, 2026
Q3 FY2026 Jan 31, 2026
Q2 FY2026 Oct 31, 2025
Q1 FY2026 Jul 31, 2025
Q4 FY2025 Apr 30, 2025
Q3 FY2025 Jan 31, 2025
Q2 FY2025 Oct 31, 2024
Revenue
$66.32M
$71.4M
$69.4M
$70.1M
$71.1M
$77.15M
$67.17M
$47.76M
Cost of revenue
$46.68M
$50.16M
$50.85M
$50.38M
$50.17M
$53.11M
$48.79M
$33.81M
Gross profit
$19.64M
$21.25M
$18.55M
$19.72M
$20.93M
$24.04M
$18.38M
$13.95M
Selling, general and administrative
$0
$0
$0
$0
$0
$0
$0
$0
Research and development
$0
$0
$0
$0
$0
$0
$0
$0
Total operating expenses
$16.48M
$16.03M
$15.96M
$15.61M
$16.12M
$15.54M
$16.13M
$9.52M
Operating income
$3.16M
$5.22M
$2.58M
$4.11M
$4.81M
$8.5M
$2.25M
$4.43M
Interest expense
-$626K
-$631K
-$1.11M
-$1.06M
-$1.06M
-$1.16M
-$1.14M
-$442K
Income before taxes
$2.56M
$4.76M
$1.6M
$3.45M
$3.92M
$7.15M
$1.28M
$3.93M
Income taxes
$717K
$1.06M
$528K
$915K
$761K
$2.2M
-$108K
$916K
Net income
$1.84M
$3.69M
$1.08M
$2.54M
$3.16M
$4.95M
$1.38M
$3.02M
Net income attributable to common shareholders
$1.71M
$3.39M
$692K
$2.45M
$3.09M
$4.85M
$1.35M
$3.01M
EBITDA
$4.75M
$7.34M
$4.18M
$5.69M
$6.36M
$10.29M
$3.81M
$5.24M
Basic earnings per share
$0.59
$1.18
$0.24
$0.85
$1.08
$1.70
$0.47
$1.05
Diluted earnings per share
$0.58
$1.13
$0.23
$0.82
$1.04
$1.63
$0.45
$1.01
Recent news
Company coverage with links to the original publishers.
Zacks equity research analysts published reports on five stocks on October 22, 2026. Salesforce faces macroeconomic sensitivity and competition but is extending its CRM franchise through new products. S&P Global underperformed its industry with elevated costs and debt but maintains durable franchises. Intuit significantly underperformed the software industry amid a deliberate reset toward customer acquisition and tax pricing changes. Microcap stocks Kewaunee Scientific and Key Tronic both underperformed their respective industries, facing profitability and financial challenges but supported by strategic positioning and new market opportunities.
Zacks analysts published research on 12 major stocks on October 21, 2026. Salesforce maintains a balanced risk-reward profile with growth drivers from Agentforce and Data 360 offsetting macroeconomic sensitivity. S&P Global faces elevated costs and debt but benefits from recurring revenues and AI adoption. Intuit shows underperformance due to fiscal 2027 reset toward customer acquisition, though long-term growth levers remain. Microcap stocks Kewaunee Scientific and Key Tronic face profitability challenges but benefit from portfolio expansion and supply chain repositioning respectively.
Kewaunee Scientific Corporation (KEQU) reported first-quarter fiscal 2027 results with sales declining 6.7% to $66.3 million and EPS falling to $0.58 from $1.04 year-over-year. The Lab Products Group faced headwinds from challenging life sciences market conditions, though the International segment showed improved profitability through higher-margin project mix. Management remains confident in underlying demand despite extended project timelines amid geopolitical and economic uncertainty.
Although U.S. stocks closed mostly higher on Friday, there were a few notable insider trades.
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.
Ooma
The Trade: Ooma, Inc. (NYSE: OOMA) CEO and President Eric ...
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
Ex-dividend
Amount / share
Pay date
Type
Sep 9, 2019
$0.19
Sep 24, 2019
recurring
Jun 6, 2019
$0.19
Jun 21, 2019
recurring
Mar 8, 2019
$0.19
Mar 25, 2019
recurring
Dec 3, 2018
$0.19
Dec 17, 2018
recurring
Sep 10, 2018
$0.19
Sep 25, 2018
recurring
Stock splits
Historical share-structure events and their execution dates.